Evidence map›Paper›PMID 31748302›Full record

ArticleBMJ open2019

Adaptation of potentially preventable medication-related hospitalisation indicators for Indigenous populations in Australia using a modified Delphi technique.

Jean Marie Spinks, Lisa M Kalisch Ellett, Geoffrey Spurling, Theo Theodoros, Daniel Williamson, Amanda J Wheeler

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jean Marie SpinksCentre for Applied Health Economics, Menzies Institute for Health Queensland, Griffith University, Brisbane, Queensland, Australia j.spinks@griffith.edu.au.ORCID 0000-0002-8128-8872
Lisa M Kalisch EllettSansom Institute for Health Resarch, School of Pharmacy and Medical Sciences, Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia.
Geoffrey SpurlingPrimary Care Clinical Unit, University of Queensland, Brisbane, Queensland, Australia.
Theo TheodorosAddiction and Mental Health Services, Metro South, Brisbane, Queensland, Australia.
Daniel WilliamsonAboriginal and Torres Strait Islander Health Branch, Queensland Health, Brisbane, Queensland, Australia.
Amanda J WheelerMenzies Institute for Health Queensland, Griffith University, Brisbane, Queensland, Australia.ORCID 0000-0001-9755-674X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesOne of the outcomes of a medication review service is to identify and manage medication-related problems (MRPs). The most serious MRPs may result in hospitalisation, which could be preventable if appropriate processes of care were adopted. The aim of this study was to update and adapt a previously published set of clinical indicators for use in assessing the effectiveness of a medication review service tailored to meet the needs of Indigenous people, who experience some of the worst health outcomes of all Australians.

designA modified Delphi technique was used to: (i) identify additional indicators for consideration, (ii) assess whether the original indicators were relevant in the context of Indigenous health and (iii) reach consensus on a final set of indicators. Three rounds of rating were used via an anonymous online survey, with 70% agreement required for indicator inclusion.

settingThe indicators were designed for use in Indigenous primary care in Australia.

participantsThirteen panellists participated including medical specialists, general practice doctors, pharmacists and epidemiologists experienced in working with Indigenous patients.

resultsPanellists rated 101 indicators (45 from the original set and 57 newly identified). Of these, 41 were accepted unchanged, seven were rejected and the remainder were either modified before acceptance or merged with other indicators. A final set of 81 indicators was agreed. TRIAL REGISTRATION NUMBER: The trial registration for the Indigenous Medication Review Service feasibility study is ACTRN12618000188235.

Indexed as

Drug-Related Side Effects and Adverse ReactionsIndigenous PeoplesAustraliaDelphi TechniqueHospitalizationHumansclinical indicatorsIndigenous healthmedication reviewpotentially preventable medication-related hospitalisations

Identifiers

PMID31748302
PMCPMC6887044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.